VCP Scanner
Stock Screener
Filter stocks with fundamental & technical criteria
Technical Scanner
RSI, Moving averages & volume momentum signals
Market Themes
Curated industry baskets & thematic leaders
Earnings Hub
Calendar, EPS surprise stats & earnings transcripts
Market News
Real-time market intelligence & AI overviews
Insider Buying
SEC Form 4 corporate insider purchases
Minervini — VCPContraction bases in Stage 2 uptrends
Minervini — Trend TemplateFull 8-rule Stage 2 screen
O'Neil — Cup with HandleBase breakouts with RS leadership
O'Neil — CANSLIM LeadersGrowth leaders with RS ≥ 85
Qullamaggie — High Tight FlagsPower plays after a large advance
Qullamaggie — Momentum Leaders1/3/6-month strength leaders
Livermore — Pivotal PointsMulti-touch resistance breakouts
View All Playbooks...
Breakouts
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Index & ETFs
SPY vs QQQVTI vs VOOSPY vs IWM
Compare Any Stocks...
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
VisualizeInteractive multi-year financial charts
Watchlist
Breakouts
WatchlistPricing
Ctrl K
Pricing
NVCR
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Analyze deeply. Research with clarity.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • Pricing
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly market insights — free

© 2026 VCP Scanner
AboutPrivacyTermsRefund Policy
Not financial advice. Do your own research.
ScreenerBreakoutsCompareWatchlist
NVCRNovocure Ltd
$14.94$1.7B
Overview & Tools
OverviewChart Terminal ↗Visualize
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice History
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Discovery & Screens
Live BreakoutsStock ScreenerOwnership
  1. Home
  2. Financial Ratios

  1. Home
  2. Stocks
  3. NVCR
  4. Financial Ratios

Novocure Ltd (NVCR) Financial Ratios

Latest Ratios: P/E Ratio -12.2x · EV/EBITDA N/A · ROE -38.9%. (2013–2025 historical series)

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly

NVCR Valuation Multiples

Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Market Cap$1.7B$1.4B$3.2B$1.6B$7.7B$7.8B$18.8B$8.2B$3.1B$1.8B$672M
Enterprise Value$1.9B$1.6B$3.7B$1.9B$8.1B$8.1B$19.0B$8.2B$3.1B$1.8B$668M
P/E Ratio →-12.25—————961.33————
P/S Ratio2.642.205.313.1214.2714.5138.1123.3212.3910.108.10
P/B Ratio4.894.238.924.3817.4018.9239.5437.6227.3915.754.72
P/FCF————814.09132.55223.81507.85———
P/OCF————249.3593.84190.02307.82———

P/E links to full P/E history page with 30-year chart

NVCR EV Ratios

Enterprise-value multiples — capital-structure-neutral measures of total business value

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
EV / Revenue—2.486.173.8215.1515.2138.5223.2912.4310.218.06
EV / EBITDA——————481.521094.13———
EV / EBIT——————533.701620.39———
EV / FCF————863.82138.91226.24507.16———

NVCR Profitability

Margins and return-on-capital ratios measuring operating efficiency

Margins

Full margin charts and quarterly trend are on the Earnings History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Gross Margin74.5%74.5%77.3%74.8%78.6%78.5%78.5%74.8%67.7%68.6%44.2%
Operating Margin-23.5%-23.5%-28.2%-45.7%-16.6%-8.3%6.1%-0.3%-13.6%-22.2%-139.1%
Net Profit Margin-20.8%-20.8%-27.9%-40.6%-17.2%-10.9%4.0%-2.1%-25.6%-34.8%-159.1%

Return on Capital

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
ROE-38.9%-38.9%-46.7%-51.5%-21.7%-13.2%5.7%-4.4%-56.3%-48.2%-67.1%
ROA-13.3%-13.3%-14.1%-17.7%-7.9%-5.3%2.6%-1.8%-21.0%-22.5%-44.7%
ROIC-16.4%-16.4%-16.0%-21.5%-7.9%-4.5%5.1%-0.4%-19.9%-21.8%-59.0%
ROCE-28.9%-28.9%-23.5%-23.3%-8.8%-4.6%4.6%-0.3%-13.7%-17.1%-44.0%

NVCR Leverage & Debt

Solvency and debt-coverage ratios — lower is generally safer

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Debt / Equity0.850.851.901.641.321.420.950.771.330.860.68
Debt / EBITDA——————11.3922.49———
Net Debt / Equity—0.551.440.981.060.910.43-0.050.080.17-0.02
Net Debt / EBITDA——————5.17-1.50———
Debt / FCF————49.736.352.43-0.70———
Interest Coverage——-10.36-38.41-9.68-5.501.980.34-1.92-3.15-16.55

NVCR Liquidity & Efficiency

Short-term solvency ratios and asset-utilisation metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Current Ratio2.902.901.465.787.007.538.805.104.984.887.10
Quick Ratio2.712.711.425.566.827.368.564.824.634.446.41
Cash Ratio2.052.051.275.086.116.587.523.803.813.655.96
Asset Turnover—0.810.490.440.450.470.470.730.730.670.29
Inventory Turnover4.064.063.913.363.914.703.883.743.552.521.81
Days Sales Outstanding—64.2461.5655.2671.9566.4574.1866.4553.7460.9627.91

NVCR Shareholder Yields

Earnings, FCF, buyback, and dividend yields — total returns to shareholders

Dividends

Full dividend history and growth charts are on the Dividend History page

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Dividend Yield———————————
Payout Ratio———————————

Total Shareholder Return Metrics

MetricTTMFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016
Earnings Yield——————0.1%————
FCF Yield————0.1%0.8%0.4%0.2%———
Buyback Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Total Shareholder Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%
Shares Outstanding—$111M$108M$106M$105M$103M$109M$97M$92M$89M$86M

Key Metrics

Growth RegimeAccelerating
ProfitabilityStrained
Balance SheetAdequate
Cash FlowMixed
Top Statement Risk

Dependence on LUNAR trial success

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Gross Margin Holds, Operating Leverage Emerges

According to recent SEC filings, NVCR's gross margin reached 77.6% in 2026Q2, up from 73.9% a year earlier, while operating margin improved to -5.8% from -24.9%, suggesting early operating leverage.

The gross margin expansion to 77.6% in 2026Q2, from 73.9% in 2025Q2, indicates stable pricing power and efficient manufacturing of disposable arrays. Operating margin improved dramatically to -5.8% from -24.9% year-over-year, reflecting revenue growth outpacing fixed cost increases. However, the persistent negative operating margin underscores that the company has not yet achieved scale to cover its heavy R&D and SG&A investments, which combined still consume 83% of revenue.

Return on Capital Still Negative but Improving

Based on reported figures, NVCR's ROIC improved to -1.7% in 2026Q2 from -10.2% in 2026Q1, and ROE improved to -4.7% from -21.2%, indicating a narrowing of losses relative to invested capital.

The improvement in ROIC and ROE is driven by a combination of higher revenue and a reduced asset base, as total assets contracted from $1.4B in 2025Q3 to $795M in 2026Q2. Despite the improvement, returns remain deeply negative, implying the company is still destroying value on a trailing basis. The trend suggests that if the LUNAR-driven growth continues, the company could approach breakeven returns within the next few quarters, but the sustainability depends on maintaining revenue momentum.

Working Capital Efficiency Improves with Negative CCC

As reported in financial statements, NVCR's cash conversion cycle improved to -131 days in 2026Q2 from -60 days in 2025Q2, driven by a DPO of 286 days, indicating strong supplier leverage.

The negative cash conversion cycle of -131 days in 2026Q2 reflects a significant extension in days payable outstanding to 286 days, which appears to be a deliberate strategy to conserve cash. DSO has improved to 59 days from 71 days a year earlier, suggesting better collection efficiency, while DIO remains elevated at 95 days, possibly reflecting inventory buildup for new indications. The negative CCC provides a source of working capital financing, but the reliance on extended payables may strain supplier relationships if growth slows.

Leverage Normalizes After Peak

According to recent SEC filings, NVCR's debt-to-equity ratio fell to 0.69 in 2026Q2 from a peak of 2.34 in 2025Q3, as total debt declined from $797.9M to $233.4M, improving balance sheet flexibility.

The sharp deleveraging from 2025Q3 to 2026Q2 suggests a deliberate reduction in debt, possibly funded by cash reserves or a refinancing event. Interest coverage remains negative due to operating losses, but the lower debt load reduces refinancing risk. However, the company still carries a net loss and a modest cash position of $93.7M, so the path to cash-flow breakeven remains critical; if growth decelerates, the company may need to raise additional capital, potentially dilutive.

Liquidity Buffer Strengthens but Remains Thin

Based on reported figures, NVCR's current ratio improved to 2.89 in 2026Q2 from 1.55 in 2025Q3, while cash stood at $93.7M, providing a modest buffer against near-term obligations.

The current ratio of 2.89 indicates that current assets cover current liabilities nearly three times, a comfortable level on paper. However, the absolute cash balance of $93.7M is relatively small relative to the quarterly operating loss of -$15.7M, implying a runway of roughly six quarters at the current burn rate. The improvement in liquidity is partly due to the reduction in debt, but the company's ability to withstand a prolonged downturn or a delay in the LUNAR ramp remains uncertain.

Misapplied Metric: EV/EBITDA

The most commonly misapplied ratio for NVCR is EV/EBITDA, which is meaningless given negative EBITDA; instead, investors should focus on price-to-sales and cash burn adjusted for stock-based compensation.

EV/EBITDA is frequently cited for NVCR, but with negative EBITDA, the ratio is undefined and provides no insight. A more appropriate metric is EV/Sales, which at 3.02 reflects the market's pricing of future growth, but this must be adjusted for the significant stock-based compensation that inflates operating cash flow. Investors should also monitor the cash conversion cycle and the trajectory of operating margin, as these better capture the underlying economics of the recurring-revenue model.

Download Financial Ratios Data

Includes 30+ ratios · 13 years · Updated daily

Consensus & Technical Research Suite
Open NVCR Terminal

NVCR Chart Terminal

WASM

Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.

Launch Terminal

Live Breakouts Feed

LIVE

High-probability breakout stocks crossing their pivot across 5 pattern engines.

Explore Setups

Intrinsic Valuation

DCF models, multiple analysis, and analyst estimates.

Check Valuation

Historical Returns

10-year return with dividends reinvested.

Calculate

Peer Comparison

Compare growth, multiples, and margins vs sector.

Compare

NVCR — Frequently Asked Questions

Quick answers to the most common questions about buying NVCR stock.

What is Novocure Ltd's P/E ratio?

Novocure Ltd's current P/E ratio is -12.2x. This places it at the 50th percentile of its historical range.

What is Novocure Ltd's ROE?

Novocure Ltd's return on equity (ROE) is -38.9%. The historical average is -39.3%.

Is NVCR stock overvalued?

Based on historical data, Novocure Ltd is trading at a P/E of -12.2x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.

What are Novocure Ltd's profit margins?

Novocure Ltd has 74.5% gross margin and -23.5% operating margin.